Imported chikungunya fever presenting with monoarthritis and biphasic rash: a diagnostic challenge in a non-endemic Europe

View at publisher Summarise with VIRAT
Authors: Dzhaner Haledinov Bashchobanov, Radina Andonova, Silvia Toteva, Elitsa Panayotova, Iva Trifonova, Georgi T. Popov
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

We present the first reported case of chikungunya virus (CHIKV) infection in Bulgaria, in a young 27-year-old man who returned from the Seychelles in early January 2026. The patient initially reported monoarthritis of the left ankle, followed the next day by a maculopapular rash involving the trunk and legs and a fever of 38°C that same evening (Figure 1A and D). Over the following days, he developed polyarthritis affecting both ankles and both wrists. He was admitted to the clinic on the fifth day after symptom onset, where laboratory tests revealed lymphopenia (Figure 1B). Supportive and symptomatic treatment with paracetamol was initiated, and blood samples were taken to test for dengue, Zika, CHIKV and yellow fever viruses. RT-PCR was positive for CHIKV and negative for the other mosquito-borne viral infections. After the results were obtained, diclofenac was added to the treatment regimen, and prothrombin time was monitored (Figure 1C). By Day 7, the patient’s condition had improved: joint pain had subsided, the rash was regressing (Figure 1E), he was afebrile and his lymphocyte count was increasing. After 2 days, the lymphocyte count began to drop again, and the rash reappeared, this time affecting the arms (Figure 1F). Joint involvement recurred, with pain and swelling in the left ankle (Figure 1G), and over the following days it again progressed to oligoarthritis involving the same joints. Molecular and serological tests were repeated, revealing viremia and absence of antibodies. The patient was discharged on Day 16 after symptom onset, with persistent arthralgia, no rash or fever, a normal lymphocyte count and still no evidence of antibody formation. Therapy with meloxicam 15 mg/day was prescribed for 1 month. Arthralgia persists for more than a month after symptom onset.

Fields of Study & Subjects

Mosquito-borne diseases and control Viral Infections and Vectors Vector-borne infectious diseases

Publication details

Journal / source
QJM
Volume
119
Issue
9
Pages
727–728
Publication date
24 March 2026
Language
EN